ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Virology
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1631386
(British English) Mapping Cross-Reactive Residues in the G-H Loop of Foot-and-Mouth Disease Virus: Insights for Serotype-Specific Design
Provisionally accepted- 1The Pirbright Institute, Ash Road, Pirbright, Woking, United Kingdom
- 2University of Surrey, School of Veterinary Medicine, Department of Comparative, Guilford, United Kingdom
- 3Department of Foot and Mouth Disease, Veterinary Serum and Vaccine Research Institute,, Cairo, Egypt
- 4Istituto Zooprofilattico Sperimentale della Lombardia e Dell'Emilia Romagna (IZSLER), Via Bianchi 7/9, Brescia, Italy, Brescia, Italy
- 5Department of Virology, Animal and Plant Health Agency, Weybridge, United Kingdom, Weybridge, United Kingdom
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Foot-and-mouth disease virus (FMDV) has a hypervariable G-H loop region within the VP1 capsid protein. This structure is associated with virus neutralisation and contains the virus attachment motif (RGD) which binds to the cellular integrin receptor facilitating virus entry for all seven FMDV serotypes. Methods: Six monoclonal antibodies (Mabs) were tested against ten peptides representing the wildtype G-H loops of serotypes O, A, SAT1 and SAT2. D9 and B2 Mabs were raised against serotype O and tested against three more sets of peptides; (1) nine overlapping peptides with one amino acid difference, (3) Alanine scanning peptide, both for O1K strain and (4) four mutated peptides one for A22 and three for SAT2 strains in the enzyme-linked immunosorbent assay format with correlation to virus neutralisation test. Results: The D9 Mab was bound to peptides corresponding to the G-H loops of serotype O, A, and SAT1 strains, but only neutralised serotype O and SAT1 strains in the virus neutralisation test. The B2 Mab is also bound to serotype O and SAT1 but only neutralised serotype O. Using a set of overlapping peptides, the binding region for the D9 Mab was confirmed as amino acid positions 144, 147 and148. An additional critical amino acid residue at position 145R was identified using a set of alanine scanning peptides. The binding region for B2 Mab appears to be upstream of RGD as B2 showed lower binding to peptides lacking the first three amino acids of the GH-loop peptides. These critical amino acids were further confirmed by designing modified SAT2 and A peptides at these positions, which led to a significant improvement in the binding ability of D9 but not B2. Conclusion: These findings help to map cross-reactive epitopes within the G-H loop which may contribute to the interserotypic cross-reactivity observed in diagnostic serological assays giving insights that motivate the design of custom peptides that have improved serotype specificity.
Keywords: FMDV, overlapping, Alanine scanning, G-H loop neutralizing epitope, G-H loop peptides, inter-serotypes cross-reactivity, D9 and B2 Mab
Received: 19 May 2025; Accepted: 07 Jul 2025.
Copyright: © 2025 Yassin, Ludi, Grazioli, Brocchi, Horton, King and Asfor. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Amin S Asfor, Department of Virology, Animal and Plant Health Agency, Weybridge, United Kingdom, Weybridge, United Kingdom
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.